From: Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers
uPA−/PAI-1+ | uPA+/PAI-1+ | uPA +/PAI-1- | uPA−/PAI-1- | |
---|---|---|---|---|
Number of patients | 85 | 92 | 35 | 135 |
Median level of uPA (ng/mg; min-max) | 1.7 (0.19–2.9) | 4.7 (3.0–12.9) | 4.7 (3–7.3) | 1.2 (0.0–2.9) |
Median level of PAI-1 (ng/mg; min-max) | 21.1 (14.0–87.8) | 22.6 (14.0–130) | 9.56 (5.5–13.8) | 6.7 (2.9–10.6) |